Sclerosis: all 3,103 studies

Page 20 of 32. Open to participants first (314), then studies with results posted, then the rest; newest registration first within each.

• Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple SclerosisCompletedNCT03122873
• Effect of MD1003 in Amyotrophic Lateral SclerosisCompletedNCT03114215Phase 2
• Virtual Task in Amyotrophic Lateral SclerosisCompletedNCT03113630Not applicable
• Reduced-intensity Immunoablation and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple SclerosisStatus unknownNCT03113162Phase 1
• Study of myMS in Participants With a Diagnosis of Multiple SclerosisCompletedNCT03111394
• From Clinic to Community: An Information and Communication Technology (ICT) Home-Based Exercise Training System for Translating Clinical FindingsCompletedNCT03108950Not applicable
• Improved Detection of Multiple Sclerosis Plaques in Inversion Recovery by Optimization of Sequence ParametersCompletedNCT03108573
• Trial of Amivita in Amyotrophic Lateral SclerosisStatus unknownNCT03103815Not applicable
• Video Game-based Therapy for Arm Weakness In Progressive Multiple SclerosisCompletedNCT03094364Not applicable
• A Multicenter Observational Study to Evaluate Pediatric Multiple Sclerosis in BrazilActive, not recruitingNCT03087136
• Transplantation of Autologous Peripheral Blood Mononuclear Cells for Amyotrophic Lateral SclerosisCompletedNCT03085706Not applicable
• Effectiveness of Acceptance and Commitment Therapy Self-Help for Carers of People With Multiple SclerosisStatus unknownNCT03077971Not applicable
• Amyotrophic Lateral Sclerosis: a New ParadigmCompletedNCT03073239
• Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis.Status unknownNCT03069170Phase 1
• Pirfenidone as Treatment of Skin Fibrosis in Systemic SclerosisStatus unknownNCT03068234Phase 2/3
• Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron DiseaseStatus unknownNCT03067857Phase 1/2
• Sleep, Physical Activity and Multiple Sclerosis Symptoms in Pediatric Multiple SclerosisCompletedNCT03067025
• The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc )Status unknownNCT03059979Early Phase 1
• The Effects of Exercise in Patients With Systemic SclerosisCompletedNCT03058887Not applicable
• To Compare the Efficacy of Combination Therapy vs Monotherapy for Pulmonary Arterial Hypertension in Systemic SclerosisStatus unknownNCT03053739Phase 4
• Multiple Sclerosis: The Role of Mitochondrial Dysfunction in IR ResistanceCompletedNCT03052595
• Effect of Video Game Based Physical Activity Training in Persons With Multiple SclerosisCompletedNCT03045380Not applicable
• Physiotherapist-guided Home Exercise in Moderate to Severe MSCompletedNCT03039400Not applicable
• NeuRx Diaphram Pacing System (DPS) Use in Amyotrophic Lateral Sclerosis (ALS)WithdrawnNCT03034317Not applicable
• pH-weighted MRI in Multiple Sclerosis: A Surrogate Marker of Tissue Metabolic StressCompletedNCT03028675
• Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary RaynaudCompletedNCT03027674Early Phase 1
• Ocrelizumab Effects on Physiological and Cognitive Changes in Multiple SclerosisCompletedNCT03025269
• A Clinical Trial to Evaluate the Safety and Efficacy of Fycompa in Subjects With Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT03020797Not applicable
• Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic SclerosisCompletedNCT03007004Phase 2
• Multiple Sclerosis and PilatesCompletedNCT03006900Not applicable
• Evaluation of the Safety, Tolerability, and Efficacy of Orally Administered PTL201 in MS Patients With Spasticity-related SymptomsStatus unknownNCT03005119Phase 2
• Characteristics and Predictors of Progression of an Egyptian Multiple Sclerosis CohortCompletedNCT03004794
• Clinical Importance of Glucose Regulation in Relapsing MSStatus unknownNCT03004079
• Multiple Sclerosis Produces Cardiovascular Subclinical DysfunctionStatus unknownNCT03001284
• Guided Versus Non-guided Pelvic Floor Exercises for Urinary Incontinence in Relapsing-Remitting Multiple SclerosisCompletedNCT03000647Not applicable
• Testosterone for Fatigue in Men With MSWithdrawnNCT03000127Phase 2
• Evaluation of Potential Accumulation of Gadolinium (Dotarem and Multihance) in the French Observatory of Multiple Sclerosis (Www.Ofsep.Org/)Status unknownNCT02992847
• Escalated Application of Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis PatientsCompletedNCT02987413Phase 1
• Pilot Diet Study for Multiple SclerosisCompletedNCT02986893Not applicable
• A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple SclerosisCompletedNCT02977533Phase 1
• ADMSCs for the Treatment of Systemic SclerosisCompletedNCT02975960Not applicable
• Demographics, Clinical and Paraclinical Characteristics of Multiple Sclerosis in EgyptCompletedNCT02970370
• Bioenergetics and Protein Metabolism in Sporadic Amyotrophic Lateral SclerosisStatus unknownNCT02969759Early Phase 1
• Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain MetastasesTerminatedNCT02967380Not applicable
• Retrospective Observational Study About Long-term Effect of Fampridine in Patients With Multiple SclerosisStatus unknownNCT02966808
• Validation of a Laboratory Test Measuring Natalizumab (Tysabri®) Serum Levels in MSCompletedNCT02965170
• Neurorehabilitation on Upper Limb and on Fatigue in Multiple SclerosisStatus unknownNCT02960984Not applicable
• Dimethyl Fumarate Treatment of Primary Progressive Multiple SclerosisCompletedNCT02959658Phase 2
• Monitoring of Multiple Sclerosis (MS) Participants With the Use of Digital Technology (Smartphones and Smartwatches) - A Feasibility StudyCompletedNCT02952911Not applicable
• Plantar Pressure Distribution in Patient With Multiple SclerosisStatus unknownNCT02947906
• CNS10-NPC-GDNF for the Treatment of ALSCompletedNCT02943850Phase 1
• Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic ConditionsWithdrawnNCT02939859Phase 1
• National Multicenter, Controlled, Single-blind Study With Two Parallel Groups Evaluating the Safety and Efficacy of Sequential Treatment With Mitoxantrone and Interferon Versus Interferon Alone in Patients With Strong Risk of Progression in the Initial Phase of Multiple SclerosisCompletedNCT02937285Phase 3
• Non-interventional Study to Assess Adherence to Treatment for Patients With RMS (MAIN-MS)CompletedNCT02921035
• Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral SclerosisStatus unknownNCT02917681Phase 1/2
• Quantitative Fatigue and Muscle Performance in Multiple SclerosisStatus unknownNCT02913209
• Hydroxychloroquine in Primary Progressive Multiple SclerosisCompletedNCT02913157Phase 2
• Optical Coherence Tomography (OCT) Trial in Multiple SclerosisCompletedNCT02907281
• Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarateTerminatedNCT02901106Phase 4
• Electrophysiological Study of Spatiotemporal Gait Parameters in Patients in Early Stage of Multiple SclerosisCompletedNCT02896933
• 3D Phase Sensitive Inversion Recuperation MRI to Detect and Characterize Multiple Sclerosis Spinal Cord LesionsTerminatedNCT02896647
• Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung DiseaseCompletedNCT02896205Phase 3
• Virtual Reality and Robot Assisted Gait Training in Patients With Multiple SclerosisStatus unknownNCT02896179Not applicable
• Paris Visual Learning Test: a New French Task for Assess Visual Learning and Memory to Multiple Sclerosis PatientsCompletedNCT02893683
• The French Multiple Sclerosis RegistryStatus unknownNCT02889965
• Benefits Evaluation of Selfia® Adapted Underwear for MS Patients Performing Self-catheterizationWithdrawnNCT02889419Not applicable
• French Adaptation of the California Card Sorting Task (CCST) in Multiple SclerosisCompletedNCT02887352
• Evaluation of a Web-Based Fall Prevention Program on People With Multiple SclerosisCompletedNCT02885233Not applicable
• Changes in Speed, Endurance and Balance in Women Patients With Multiple Sclerosis After 4 & 8 Weeks of Aquatic Exercise TrainingCompletedNCT02882724Phase 1
• Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral SclerosisStatus unknownNCT02881489Phase 1
• Therapeutic Treatment of Amyotrophic Lateral SclerosisStatus unknownNCT02881476Phase 1
• Disability, Perceived Social Support and Quality of Life in Multiple SclerosisCompletedNCT02880553
• Effect of Transcutaneous Electrical Nerve Stimulation on Cognition in Multiple Sclerosis PatientsStatus unknownNCT02876536Not applicable
• A Reeducation Program to Effort to Improve the Walking of Multiple Sclerosis PatientsTerminatedNCT02874677Not applicable
• Noninvasive Assessment of Neuronal Damage by MRI Sodium ( 23Na ) in Amyotrophic Lateral SclerosisStatus unknownNCT02874209Not applicable
• Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MNDCompletedNCT02870634Phase 1
• How Does Strength Training and Balance Training Affect Gait Function and Fatigue in Patients With Multiple Sclerosis?CompletedNCT02870023Not applicable
• To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MSWithdrawnNCT02869425Phase 3
• Correlation Between PET and Advanced MRI in Multiple SclerosisCompletedNCT02869360
• Safety and Tolerability of Antiretroviral (Triumeq) in Patients With Amyotrophic Lateral Sclerosis (ALS).CompletedNCT02868580Phase 2
• Topical Everolimus in Patients With Tuberous Sclerosis ComplexWithdrawnNCT02860494Phase 2/3
• A Patient Centric Motor Neuron Disease Activities of Daily Living ScaleCompletedNCT02852278
• SSRIs vs. TCAs for Depression in ALS PatientsCompletedNCT02851914Early Phase 1
• GTA-MEG as a Biomarker for Cognition in MSCompletedNCT02851342
• Short and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine.CompletedNCT02849782Phase 4
• Re-training to Effort (RE) According to the Severity of Multiple Sclerosis: Preliminary Assessments Based on Fatigue and Quality of LifeCompletedNCT02848976
• The Effects of Focal Vibration on Spasticity in Multiple Sclerosis PatientsStatus unknownNCT02848898Not applicable
• MS Mosaic: A Longitudinal Research Study on Multiple SclerosisCompletedNCT02845635
• Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum DisordersStatus unknownNCT02836327
• Role of Virtual Reality in MS RehabilitationCompletedNCT02834533Not applicable
• Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.TerminatedNCT02833714
• Vocal Intervention in Systemic SclerosisStatus unknownNCT02821663Not applicable
• Seoul National University Hospital Systemic Sclerosis CohortStatus unknownNCT02819947
• MSFC Versus DAM. A Smartphone Application for Multiple Sclerosis Self-assessment.CompletedNCT02814487
• Default Mode Network in Multiple SclerosisStatus unknownNCT02810314Not applicable
• FOLLOW HEART TRANSPLANT FOR ACHIEVING THE HEART PRIMITIVE RELATED SCLERODERMA SYSTEMICStatus unknownNCT02808481
• Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple SclerosisNo longer availableNCT02807285
• Correlation Between the 'Nine Holes Peg Test' Performance and the Triple Stimulation Technique Within a Group a Patients With Multiple SclerosisCompletedNCT02805634Not applicable
• Bosentan Treatment of Digital Ulcers Related to Systemic SclerosisCompletedNCT02798055
• Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMSCompletedNCT02797015Phase 1

← Sclerosis overview